Photophobia in a Patient with High Indinavir Plasma Concentrations

Therapeutic Drug Monitoring

Volumn 25, Issue 6, 2003, Pages 735-737

  Huitema, Alwin D R ^a   Kniper, Rob A J ^a   Meenhorst, Pieter L ^a   Mulder, Jan W ^a   Beijnen, Jos H ^a,b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PHOTOPHOBIA; PRIORITY JOURNAL; UVEITIS;

ADULT; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MALE; PHOTOPHOBIA;

EID: 0345060780     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200312000-00013     Document Type: Article

References (8)

1. Van Heeswijk RPG, Hoetelmans RMW, Harms R, et al. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection. J Chromatogr B. 1998; 719:159-168.
2. Soldin OP, Elin RJ, Soldin SJ. Therapeutic drug monitoring in human immunodeficiency virus/acquired immunodeficiency syndrome. Quo vadis? Arch Pathol Lab Med. 2003;127:102-105.
3. Gariano RF, Cooney EL. Uveitits following administration of the protease inhibitor indinavir to a patient with AIDS. Clin Infect Dis. 1997;24:529.
4. Fournier S, Deplus S, Janier M, et al. Uvéite antérieure chez des patients infectes par le VIH. 3 cas chez des patients traités par une antiprotéase. Presse Med. 1998;27:844-848.
5. Hachey DM, Force RW, Schott J, et al. Indinavir crystalluria in an HIV-positive man. Ann Pharmacother. 2000;34:403.
6. Dieleman JP, Gyssens IC, van der Ende ME, et al. Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients. AIDS. 1999; 13:473-478.
7. Carr A, Samaras K, Chisholm DJ, et al. Pathogenesis of HIV-protease inhibitor-associated peripheral lipodystrophy, hyperlipiaemia, and insulin resistance. Lancet. 1998;352:1881-1883.
8. James CW, McNelis KC, Cohen DM, et al. Recurrent ingrown toenails secondary to indinavir/ritonavir combination therapy. Ann Pharmacother. 2001;35: 881-884.